These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19254831)

  • 21. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
    Joka D; Wahl K; Moeller S; Schlue J; Vaske B; Bahr MJ; Manns MP; Schulze-Osthoff K; Bantel H
    Hepatology; 2012 Feb; 55(2):455-64. PubMed ID: 21993925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of preoperative carbohydrate loading on the changes in serum tumor necrosis factor receptors 1 and 2 and insulin resistance in patients of colon carcinoma].
    An GQ; Zhao XL; Gao YC; Wang GY; Yu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2041-4. PubMed ID: 19080431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cytokeratin 18 as a biomarker for gastric cancer.
    Oyama K; Fushida S; Kinoshita J; Okamoto K; Makino I; Nakamura K; Hayashi H; Inokuchi M; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fujimura T; Ohta T
    Clin Exp Med; 2013 Nov; 13(4):289-95. PubMed ID: 22825587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of serum M30 and M65 levels in patients with breast cancer.
    Tas F; Karabulut S; Yildiz I; Duranyildiz D
    Biomed Pharmacother; 2014 Oct; 68(8):1135-40. PubMed ID: 25465151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.
    Chu T; Jiang L; Ying W; Han B
    Clin Transl Oncol; 2017 Mar; 19(3):326-331. PubMed ID: 27468866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma.
    Barut O; Vural P; Şirin Ş; Aydin S; Dizdar Y
    Acta Odontol Scand; 2012 Jul; 70(4):303-8. PubMed ID: 21815836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum M65 as a biomarker for metastatic renal cell carcinoma.
    Yildiz I; Sen F; Kilic L; Keskin S; Duranyildiz D; Bilgin E; Disci R; Ekenel M; Darendeliler E; Bavbek S; Basaran M
    Clin Genitourin Cancer; 2013 Sep; 11(3):290-6. PubMed ID: 23391372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.
    Esmaeil N; Moayedi B; Gharagozloo M; Maracy MR
    Hemoglobin; 2013; 37(4):404-10. PubMed ID: 23600495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
    Ullen A; Schwarz S; Lennartsson L; Kalkner KM; Sandstrom P; Costa F; Lennernas B; Linder S; Nilsson S
    Scand J Urol Nephrol; 2009; 43(2):98-103. PubMed ID: 19101859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
    Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
    J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction.
    Adlbrecht C; Hoetzenecker K; Posch M; Steiner S; Kopp C; Hacker S; Auer J; Horvath R; Moser B; Roth G; Wolner E; Lang IM; Ankersmit HJ
    Eur J Clin Invest; 2007 May; 37(5):372-80. PubMed ID: 17461983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
    Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
    Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.
    Guo YJ; Liu G; Wang X; Jin D; Wu M; Ma J; Sy MS
    Cancer Res; 1994 Jan; 54(2):422-6. PubMed ID: 7506122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.
    Olofsson MH; Ueno T; Pan Y; Xu R; Cai F; van der Kuip H; Muerdter TE; Sonnenberg M; Aulitzky WE; Schwarz S; Andersson E; Shoshan MC; Havelka AM; Toi M; Linder S
    Clin Cancer Res; 2007 Jun; 13(11):3198-206. PubMed ID: 17545523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.
    Omohwo C; Nieroda CA; Studeman KD; Thieme H; Kostuik P; Ross AS; Holter DR; Gushchin V; Merriman B; Sardi A
    J Am Coll Surg; 2009 Sep; 209(3):308-12. PubMed ID: 19717034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.
    Elalfy H; Besheer T; Arafa MM; El-Hussiny MA; El Latif MA; Alsayed SAM
    J Gastrointest Cancer; 2018 Sep; 49(3):260-267. PubMed ID: 28361205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.